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BACKGROUND/PURPOSE: Tuberculosis (TB) is an endemic disease in Taiwan and it usually affects 
the lung. Spinal TB accounts for 1–3% of all TB infections. The purpose of this study was to investigate 
the clinical manifestations, management, outcomes and drug susceptibility of Mycobacterium tuberculosis 
in non-HIV-infected patients with spinal TB.
METHODS: From January 1998 to December 2007, we retrospectively reviewed the medical charts of 
adult patients with a diagnosis of spinal TB. Only those with positive culture results and/or characteristic 
pathologic findings were enrolled. Demographic data, clinical manifestations and susceptibility to 
anti-TB drugs were reviewed and analyzed.
RESULTS: During the study period, 38 patients (23 men, 15 women) with spinal TB were identified and 
the mean age was 68 years. The median duration of symptoms was 60 days (range, 3–720 days). Amongst 
the 38 patients, back pain (100%) was the most common clinical symptom, followed by weakness (53%) 
and numbness (26%). The lumbar spine (15 patients, 39%) was the most commonly involved site, followed 
by the thoracic spine (14 patients, 37%). Concomitant pulmonary TB was found in 12 patients (32%). 
Three patients (8%) had concurrent bacterial or fungal infections. Almost all of the patients (35 patients, 
92%) were successfully treated with surgery and anti-TB medications. The erythrocyte sedimentation rate 
was followed up in 16 patients before and after therapy and a significant decline was observed after treatment 
(p = 0.004). No mortality was related to spinal TB.
CONCLUSION: Insidious clinical course and ambiguous manifestations of spinal TB often delay and 
hinder the accuracy of diagnosis of spinal TB. In addition to pyogenic osteomyelitis, spinal TB should be 
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Introduction
Tuberculosis (TB) is an emerging international problem de-
spite advances in the methods of diagnosis and treatment. 
The resurgence of TB can be expected to be associated with 
a concomitant increase in the incidence of extra-pulmonary 
TB, including Pott’s disease.1–3 There are a number of pub-
lications regarding spinal TB in other countries,4,5 but in 
Taiwan only a few studies on spinal TB have been conducted, 
and most of them focused on the image features of diag-
nosis.6,7 The clinical characteristics of adult spinal TB have 
never been thoroughly reviewed in Taiwan. Hence, the pur-
pose of this 10-year retrospective study was to characterize 
the clinical manifestations, microbiological features and the 
treatment outcome of patients with spinal TB.
Methods
Patients
We retrospectively reviewed the medical charts of all pa-
tients diagnosed with spinal TB at China Medical University 
Hospital, Taichung, Taiwan from January 1998 to December 
2007. All enrolled patients were adults (≥ 18-years-old), and 
non-HIV infected. Spinal TB was diagnosed when the fol-
lowing criteria were met: (1) presence of osteomyelitis at one 
or more vertebral segment; (2) presence of Mycobacterium 
tuberculosis isolated from the abscess of a tissue biopsy 
specimen; and (3) histology of tissue specimen demonstrat-
ing caseating granuloma or granulomatous inflammation 
with positive acid-fast bacillus smear. Patients who fulfilled 
criterion (1) and criterion (2) or (3) were included in this 
study. Probable cases that we could not confirm micro-
biologically or pathologically but responded to anti-TB 
therapy were excluded. Patients’ demographic data, under-
lying diseases, duration of symptoms, laboratory results, 
radiographic findings, culture results, histopathologic find-
ings, treatment regimen and clinical outcomes were reviewed 
and analyzed.
Laboratory methods
Various culture and identification systems were used during 
this study period. Before 1998, Lowenstein-Jensen medium 
(Becton Dickinson, Sparks, MD, USA) was used for TB 
identification based on traditional biochemical reactions 
(nitrate reduction and niacin test). In 1999, the BACTEC 
MGIT 960 system (Becton Dickinson) was introduced, 
then clinical specimens were processed and the centrifuged 
sediment was inoculated in Lowenstein-Jensen medium 
(Becton Dickinson) and Middlebrook 7H9 broth (Becton 
Dickinson). The cultures were incubated at 35ºC in 5% CO2 
for up to 8 weeks. The identification of TB was based on 
morphology and biochemical reactions. In 2004, the Protec 
ET system (Becton Dickinson) replaced the traditional 
biochemistry reaction methods of TB identification. Once 
growth was detected, the M. tuberculosis complex was con-
firmed by the Protec ET system and drug susceptibility 
subsequently performed.8
Statistical analysis
Statistical Package for the Social Sciences version 13.0 (SPSS 
Inc., Chicago, IL, USA) was used for statistical analysis. 
Data were presented as mean ± standard deviation (median 
value for data not distributed normally). We used paired t 
tests to examine differences between laboratory data before 
and during treatment. Qualitative variables were compared 
using Fisher’s exact test. A p value < 0.05 was considered 
statistically significant.
Results
Clinical and laboratory data
During this 10-year period, 3,240 pulmonary TB and 404 
extra-pulmonary TB cases were diagnosed. Among the extra-
pulmonary TB cases, 38 patients (23 men, 15 women) with 
spinal TB were identified, and the mean age of all patients 
was 68 years (3 patients were younger than 50 years). The 
majority of patients (> 50%) were older than 65 (Table 1). 
included in the differential diagnosis especially in elderly patients with chronic back pain accompanied by 
elevated erythrocyte sedimentation rate, and those living in the TB endemic area.
KEYWORDS: drug resistance, osteomyelitis, treatment outcome, tuberculosis
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The median duration of symptoms before diagnosis was 
60 days (range, 3–720 days). Nine patients (24%) had no 
specific underlying diseases, and 29 patients (76%) had 
comorbidities as described in Table 1. Two patients had a 
previous history of pulmonary TB. Another two patients 
with chronic obstructive pulmonary disease and systemic 
lupus erythematosus received long-term corticosteroid 
therapy before the diagnosis of spinal TB. At the time of 
diagnosis, nine patients (24%) had constitutional symptoms. 
Twelve patients (32%) had concomitant pulmonary TB. 
Four cases had other extra-pulmonary site involvement, 
including pleurae (3 cases) and liver (1 case). Back pain was 
the most common clinical complaint (38 patients, 100%), 
followed by weakness (20 patients, 53%) and numbness 
(10 patients, 26%). The mean value of C-reactive protein 
(CRP) level at presentation was 4.25 mg/L. In addition, 
most patients (89%) had elevated erythrocyte sedimenta-
tion rate (ESR; > 20 mm/hr) with an average ESR value 
of 62 mm/hr. Sixteen patients had serial ESR follow-up 
data, with a mean follow up of 10.8 months. A significant 
decline in ESR value was found between the pre- and post-
treatment ESR values (pre-treatment mean ESR = 64 mm/hr, 
post-treatment mean ESR = 31 mm/hr; p = 0.004).
Image findings
Image findings are summarized in Table 2. Magnetic reso-
nance imaging (MRI) was the most frequently used imaging 
modality in evaluating spinal lesions (35 patients, 92%); 
ten (26%) of these patients also received osteomyelitis scans, 
and the results demonstrated comparable findings to MRI. 
The lumbar spine was the most commonly involved site 
(15 patients, 39%) and the cervical spine was less commonly 
involved. The numbers of vertebral bodies involved per pa-
tient ranged between two and five (mean = 3.5). One-third 
of patients had ≥ 3 vertebral bodies involved. Additionally, 
Table 1. Demographic characteristics, clinical symptoms/
signs and initial laboratory finding of 38 spinal tuberculosis 
patientsa
Characteristics Value
Age (yr) 68 (36–86)
Age distribution (yr)
 < 65 12 (32)
 ≥ 65 26 (68)
Sex, M/F 23/15
Comorbidities, n
 Hypertension 16
 Diabetes mellitus  7
 Chronic kidney disease  7
 Cardiovascular disease  5
 Hepatitis B/hepatitis C 3/3
 Othersb  4
Duration of symptoms (d) 99 (3–720)
Clinical symptoms and signs
 Pain 38 (100)
 Weakness 20 (53)
 Numbness 10 (26)
 Fever 6 (16)
 Constitutional symptoms 3 (8)
Hematological and biochemical data
 Leukocyte count (cells/μL)  8,521 ± 3,403
 Hemoglobin (g/dL) 12.1 ± 2.3
 ESR (mm/hr) 62 ± 31
 C-reactive protein (mg/L) 4.25 ± 4.21
aData presented as mean (range), n (%) or mean ± standard deviation; 
bothers included chronic obstructive pulmonary disease, Systemic 
Lupus Erythematosus, malignancy (gastric cancer), and Gouty arthritis. 
ESR = erythrocyte sedimentation rate.
Table 2. Imaging characteristics of 38 spinal tuberculosis 
patientsa
 n (%)
Location
 Cervical 1 (2)
 Thoracic 14 (37)
 Thoracolumbar 3 (8)
 Lumbar 15 (39)
 Lumbosacral 4 (11)
 Skipped lesion (T, L)  1 (2)
Vertebra involved
 2 26 (68)
 3 8 (21)
 4 1 (2)
 5 3 (8)
Imaging findings
 Disc space involvement 32 (84)
 Paraspinal abscess 19 (50)
 Epidural compression 27 (71)
aData presented as n (%).
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more than half of the patients had disc space involvement, 
epidural compression or paraspinal abscesses.
Diagnostic methods and microbiological findings
The majority of patients (32 patients, 84%) were subjected 
to surgery and the remainder of the patients underwent 
either computed tomography (CT)-guided needle biopsy 
or CT-guided drainage. The overall sensitivity for biopsies, 
including surgical and CT-guided biopsy was 84% (32/38) 
for granulomas, 58% (22/38) for the acid-fast bacillus smear 
on Ziehl-Neelsen’s stain and 63% (24/38) for TB culture. 
There was no significant difference between each technique 
(Table 3).
Of the 24 M. tuberculosis isolates from the clinical speci-
mens, 18 (75%) were susceptible to first-line anti-TB drugs 
including isoniazid (INH), rifampicin, ethambutol, pyrazi-
namide and streptomycin. Three patients (13%) were re-
sistant to INH, one was resistant to streptomycin and 
another was resistant to both INH and rifampicin.
Treatment and outcomes
Among the 38 patients, 32 (84%) received surgical interven-
tion combined with medical treatment. Surgical interven-
tion was chosen for patients who had symptoms of epidural 
compression or joint instability problems. Three patients 
had co-infection with other microorganisms, including 
Propionibacterium, methicillin-sensitive Staphylococcus aureus 
and Candida parapsilosis; all of these patients received appro-
priate antibiotic treatment. Only four patients received 
medical anti-TB therapy alone due to a less extensive disease 
state. The choice of therapeutic regimens was based on the 
recommendations proposed by the American Thoracic 
Society, the Centers for Disease Control and Prevention, 
and the Infectious Diseases Society of America.9 The median 
treatment duration was 11 months (range, 6–32 months). 
Thirty-four patients were followed up after completion of 
anti-TB treatment, and the Frankel Scale system10 was used 
to evaluate the functional recovery of these patients. Most 
patients (24 patients, 71%) were classified on the Frankel 
scale as D and E (Table 4), which meant that they had nearly 
complete recovery without motor or sensory deficit in daily 
activities. One patient was lost to follow up and four patients 
died during treatment. The cause of death in these four 
cases was not related to spinal TB itself, and no relapse was 
reported during follow up (mean duration = 10.6 months).
Discussion
Spinal TB was first described in 1782 by Sir Percival Pott.11 
It accounts for 50% of skeletal TB,12,13 and 1–3% of all TB 
cases.14–16 In our institution, spinal TB made up 1% (38/3,644) 
of all TB cases. Unlike other reports,17,18 our subjects were 
elderly, with 55% of patients over the age of 70 years. In 
other countries, the average life expectancy for the general 
population is shorter than in Taiwan.17 Similar to other 
Table 3. Yield of computed tomography-guided biopsy/drainage and surgical biopsy for the diagnosis of spinal tuberculosisa
 CT guided biopsy/drainage Surgical biopsy Total pb
 (n = 6) (n = 32) (n = 38)
Positive granuloma 6 (100) 26 (81) 32 (84) 1.000
Positive AFB smear  4 (67) 18 (56) 22 (58) 1.000
Positive culture  4 (67) 20 (63) 24 (63) 1.000
aData presented as n (%); bFisher’s exact test. CT = computed tomography; AFB = acid-fast bacillus.
Table 4. Neurological grades, Frankel scale
 Definition n (%)
A Complete motor and sensory loss 5 (14.7)
  below the lesion
B Incomplete, some sensory loss 3 (8.8)
  below the lesion
C Incomplete, motor and sensory sparing, 2 (5.8)
  but the patient is not functional
D Incomplete, motor and sensory sparing, 19 (55.9)
  but patient can stand and walk
E Normal, complete functional recovery 5 (14.7)
Total  34 (100)
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studies,4,17 back pain was the most commonly presented 
symptom, followed by weakness and numbness. Unlike pul-
monary TB, spinal TB is seldom accompanied with symp-
toms such as fever, body weight loss or night sweating,4 
and this was clearly demonstrated in our study. Considerable 
variation in the duration of symptoms19 was also observed 
in the present study, and this may be due to the insidious 
clinical course and nonspecific manifestations of spinal 
TB.4,19 Analogous to other reports,20,21 the percentage of 
combined spinal and pulmonary TB was 32% in this study. 
Similar to the results of Pertuiset et al,18 the thoracic and 
lumbar spines were nearly equally affected and contributed 
76% of the spinal regions.
In contrast to the report by Schlesinger et al,4 our pa-
tients had a more extensive disease state with paraspinal 
abscess and epidural compression. The different severity 
levels between the present and previous study4 may be due 
to the presence of nonspecific symptoms of spinal TB in 
the elderly, and a delay in diagnosis. In this population, 
degenerative joint disease or inflammatory changes were 
usually considered to be the causes of back pain and this 
may delay early and accurate diagnosis of spinal TB.22
MRI and CT are still the most useful modes for detecting 
spinal lesions, especially MRI, which has good sensitivity 
and specificity;23,24 a total of 92% of our patients were di-
agnosed by MRI. Ten patients in this study received osteo-
myelitis scans and all the results were comparable to MRI 
findings, which is similar to the results from a prior study.25 
Osteomyelitis scans can provide a less expensive method, 
and assist with localizing the lesions in the diagnostic 
work-up.
Compared with other studies,18 more patients in this 
study received surgical intervention (32 patients, 84%). 
Although our patients were elderly and had relatively exten-
sive diseases, most of them recovered well postoperatively 
and no surgical mortality was recorded during a 10-month 
follow-up. Images, clinical symptoms, ESR and CRP are the 
most commonly used parameters to follow up the thera-
peutic response of osteomyelitis.26 In addition to the image 
studies and clinical symptoms, ESR was followed serially in 
42% of our patients before and after treatment. There was 
a significant decline in the ESR value after adequate man-
agement. Similar to other authors’ observation,22 CRP 
level was not initially elevated in our study, and the role of 
this parameter in following up the therapeutic response 
of osteomyelitis remains to be defined.26,27 Therefore, 
comparison with CRP, ESR may provide clinicians more 
useful information in evaluating the treatment response 
of spinal TB.
It is interesting to note that 8% of the patients had co-
infection with other pathogens, a finding which is infre-
quently reported in other articles.15 This phenomenon 
should remind clinicians that if the treatment response is 
not as expected, poor compliance to treatment, drug resis-
tance, inadequate debridement and/or co-infection with 
other pathogens should be considered.
In conclusion, in elderly patients with chronic back 
pain and elevated ESR, spinal TB should be included in the 
differential diagnosis. Early diagnosis with less invasive 
modalities, such as CT-guided biopsy may reduce the pa-
tient’s morbidity and improve the quality of life in these 
patients.
References
1. Martini M, Ouahes M. Bone and joint tuberculosis: a review of 
652 cases. Orthopedics 1988;11:861–6.
2. Muradali D, Gold WL, Vellend H, Becker E. Multifocal osteoartic-
ular tuberculosis: report of four cases and review of management. 
Clin Infect Dis 1993;17:204–9.
3. Shah BA, Splain S. Multifocal osteoarticular tuberculosis. 
Orthopedics 2005;28:329–32.
4. Schlesinger N, Lardizabal A, Rao J, McDonald R. Tuberculosis of 
the spine: experience in an inner city hospital. J Clin Rheumatol 
2005;11:17–20.
5. Talbot JC, Bismil Q, Saralaya D, Newton DA, Frizzel RM, Shaw DL. 
Musculoskeletal tuberculosis in Bradford—a 6-year review. Ann R 
Coll Surg Engl 2007;89:405–9.
6. Chang MC, Wu HT, Lee CH, Liu CL, Chen TH. Tuberculous 
spondylitis and pyogenic spondylitis: comparative magnetic 
resonance imaging features. Spine 2006;31:782–8.
7. Lin WY, Wang SJ, Cheng KY, Shen YY, Changlai SP. Diagnostic 
value of bone and Ga-67 imaging in skeletal tuberculosis. Clin Nucl 
Med 1998;23:743–6.
8. Heifets LB. Clinical mycobacteriology. Drug susceptibility testing. 
Clin Lab Med 1996;16:641–56.
9. Blumberg HM, Burman WJ, Chaisson RE, Daley CL, Etkind SC, 
Friedman LN, et al. American Thoracic Society/Centers for Disease 
Control and Prevention/Infectious Diseases Society of America: 
treatment of tuberculosis. Am J Respir Crit Care Med 2003;167:603–62.
10. Maynard FM Jr, Bracken MB, Creasey G, Ditunno JF Jr, 
Donovan WH, Ducker TB, et al. International standards for neu-
rological and functional classification of spinal cord injury. 
American Spinal Injury Association. Spinal Cord 1997;35:266–74.
 469
Spinal TB in central Taiwan over a 10-year period
11. Gorse GJ, Pais MJ, Kusske JA, Cesario TC. Tuberculous spon-
dylitis. A report of six cases and a review of the literature. 
Medicine (Baltimore) 1983;62:178–93.
12. Fancourt GJ, Ebden P, Garner P, Cookson JB, Wales JM, Stoyle 
TF. Bone tuberculosis: results and experience in Leicestershire. 
Br J Dis Chest 1986;80:265–72.
13. Wolfgang GL. Tuberculosis joint infection. Clin Orthop Relat Res 
1978:257–63.
14. Sharif HS, Morgan JL, al Shahed MS, al Thagafi MY. Role of CT 
and MR imaging in the management of tuberculous spondylitis. 
Radiol Clin North Am 1995;33:787–804.
15. Tali ET, Gultekin S. Spinal infections. Eur Radiol 2005;15:
599–607.
16. Nussbaum ES, Rockswold GL, Bergman TA, Erickson DL, 
Seljeskog EL. Spinal tuberculosis: a diagnostic and management 
challenge. J Neurosurg 1995;83:243–7.
17. Turgut M. Spinal tuberculosis (Pott’s disease): its clinical presen-
tation, surgical management, and outcome. A survey study on 694 
patients. Neurosurg Rev 2001;24:8–13.
18. Pertuiset E, Beaudreuil J, Liote F, Horusitzky A, Kemiche F, 
Richette P, et al. Spinal tuberculosis in adults. A study of 103 
cases in a developed country, 1980–1994. Medicine (Baltimore) 1999;
78:309–20.
19. Cormican L, Hammal R, Messenger J, Milburn HJ. Current diffi-
culties in the diagnosis and management of spinal tuberculosis. 
Postgrad Med J 2006;82:46–51.
20. Berney S, Goldstein M, Bishko F. Clinical and diagnostic features 
of tuberculous arthritis. Am J Med 1972;53:36–42.
21. Al-Saleh S, Al-Arfaj A, Naddaf H, Memish Z. Tuberculosis arthritis: 
A review of 27 cases. Ann Saudi Med 1998;18:368–9.
22. Maeda Y, Izawa K, Nabeshima T, Yonenobu K. Tuberculous 
spondylitis in elderly Japanese patients. J Orthop Sci 2008;13:16–20.
23. Danchaivijitr N, Temram S, Thepmongkhol K, Chiewvit P. 
Diagnostic accuracy of MR imaging in tuberculous spondylitis. 
J Med Assoc Thai 2007;90:1581–9.
24. Sinan T, Al-Khawari H, Ismail M, Ben-Nakhi A, Sheikh M. Spinal 
tuberculosis: CT and MRI feature. Ann Saudi Med 2004;24:437–41.
25. Lin WY, Hsieh JF. Gallium-67 citrate scan in extrapulmonary 
tuberculosis. Nuklearmedizin 1999;38:199–202.
26. Fritz J, Tzaribatchev N, Claussen CD, Carrino JA, Horger MS. 
Chronic recurrent multifocal osteomyelitis: comparison of 
whole-body MR imaging with radiography and correlation with 
clinical and laboratory data. Radiology 2009;252:842–51.
27. Lorrot M, Fitoussi F, Faye A, Mariani P, Job-Deslander C, 
Pennecot GF, et al. Laboratory studies in pediatric bone and 
joint infections. Arch Pediatr 2007;14(Suppl 2):S86–90.
